Jaguar Health, Inc.

JAGX
$2.04 (- $0.11 - 5.12%)
Last updated: 2026-10-23 20:50 UTC
JAGX Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS47010C3007
CUSIP47010C300
Market Price2.04
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-34.74
Market Cap$6.5M
Book Value0.85
Price to Book1.326
Beta0.1
52w High25.75
52w Low0.64
Next Earnings Date2026-11-12

Jaguar Health, Inc. trades under ticker JAGX on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US47010C3007, CUSIP 47010C300. Also searched as Jaguar Health.

Related researchJAGX stock priceJAGX share price47010C300Jaguar Health stockJaguar Health share price
About the Company
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing and commercializing plant-based gastrointestinal products for humans and animals. Its current business is organized around two segments, Human Health and Animal Health, covering prescription and non-prescription products for conditions such as chronic diarrhea, bowel urgency, and related gastrointestinal distress. The company’s human portfolio includes therapies for HIV-related diarrhea and other gastrointestinal indications, while its animal health activities target companion and production animals with digestive health needs. Jaguar Health also works through its subsidiaries to support proprietary products derived from sustainably sourced botanical ingredients. Headquartered in San Francisco, California, Jaguar Health plays a specialized role in the pharmaceutical market by addressing gastrointestinal disorders across both human and veterinary care.
Price History